Romesh Subramanian
InvestorVenture Partner at Scion Life Sciences
Cambridge, Massachusetts, United States
About
Romesh Subramanian is a Venture Partner at Scion Life Sciences with over 20 years of experience in pharma and biotech as a scientist, founder, and entrepreneur, having worked on nucleic acid therapeutics, biologics, and antibody conjugates. He previously served as President and CEO of Ascidian Therapeutics, was founding CEO of Dyne Therapeutics, and was an EIR at Atlas Ventures where he co-founded and led R&D at RaNA Therapeutics (later Translate Bio). Earlier he led therapeutics work at Alexion and Pfizer. He holds a B.S. from Loyola College, an M.S. from Duke University, and a Ph.D. from Emory University.
Invests in
Biotech
Experience
- Scion Life SciencesVenture Partnercurrent2025 β presentBoston, Massachusetts, United States
- Radar TherapeuticsIndependent Board Membercurrent2024 β presentSan Francisco, CA
- Ascidian TherapeuticsPresident and CEO2022 β 2023Boston, Massachusetts, United States
- Dyne TherapeuticsCSO/Founder2020 β 2021Waltham, MA
- Dyne TherapeuticsCEO/CSO/Founder2017 β 2020Cambridge, MA
- Atlas VentureEntrepreneur In Residence2017 β 2021Cambridge, MA
- Alexion Pharmaceuticals, Inc.Senior Director - Discovery Research2014 β 2017Cambridge
- RaNA TherapeuticsSenior Director and Co-founder2011 β 2014Cambridge, MA
- PFIZER INCSenior Principal Scientist2006 β 2011
- THRASOS THERAPEUTICSSenior Scientist2004 β 2006
- Dana-Farber Cancer InstitutePostdoctoral Research Fellow2001 β 2004
- Emory UniversityDoctoral Student1995 β 2001
Education
- Emory UniversityPh.D., Molecular Pharmacology1995 β 2001
- Duke UniversityM.S., Biology
- Loyola CollegeB.S, Zoology
Skills & more
+8 more
BiotechnologyBiochemistryCancerAssay DevelopmentClinical TrialsCellCROADMEFrom Romesh's professional profile.
Same school
Also attended Emory University97
+ 91 more
Also attended Duke University384
+ 378 more
Shared employers
Also worked at Radar Therapeutics1
Also worked at Dyne Therapeutics5
Also worked at Atlas Venture51
+ 45 more

































